TAS2R43
Basic information
Region (hg38): 12:11091287-11092313
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TAS2R43 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 11 | 18 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 11 | 6 | 8 |
Variants in TAS2R43
This is a list of pathogenic ClinVar variants found in the TAS2R43 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-11091387-C-A | not specified | Uncertain significance (Nov 12, 2021) | ||
12-11091489-T-C | not specified | Uncertain significance (Apr 23, 2024) | ||
12-11091567-G-C | Likely benign (Jul 25, 2017) | |||
12-11091609-C-A | not specified | Uncertain significance (Apr 09, 2024) | ||
12-11091689-T-C | not specified | Uncertain significance (Mar 06, 2023) | ||
12-11091699-C-T | not specified | Uncertain significance (Sep 16, 2021) | ||
12-11091727-A-C | not specified | Uncertain significance (Jan 16, 2024) | ||
12-11091769-C-T | not specified | Likely benign (Oct 12, 2021) | ||
12-11091809-C-T | not specified | Uncertain significance (Nov 22, 2023) | ||
12-11091839-C-T | Likely benign (Oct 01, 2024) | |||
12-11091858-T-G | not specified | Uncertain significance (Apr 20, 2024) | ||
12-11091902-T-C | not specified | Uncertain significance (Apr 22, 2022) | ||
12-11091997-A-G | not specified | Uncertain significance (Mar 08, 2024) | ||
12-11092003-T-C | Likely benign (Jul 25, 2017) | |||
12-11092034-A-T | not specified | Uncertain significance (Jan 31, 2024) | ||
12-11092043-A-C | not specified | Uncertain significance (Jul 20, 2021) | ||
12-11092111-T-C | not specified | Uncertain significance (Jul 09, 2021) | ||
12-11092122-G-C | Benign (Jul 25, 2017) | |||
12-11092124-A-C | Benign (Jul 25, 2017) | |||
12-11092131-A-G | Benign (Jul 25, 2017) | |||
12-11092132-A-G | Likely benign (Jul 25, 2017) | |||
12-11092145-G-A | Benign (Jul 25, 2017) | |||
12-11092146-T-C | Benign (Jul 25, 2017) | |||
12-11092174-A-G | not specified | Uncertain significance (Sep 22, 2023) | ||
12-11092194-C-T | Benign (Jul 25, 2017) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TAS2R43 | protein_coding | protein_coding | ENST00000531678 | 1 | 1027 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.853 | 172 | 143 | 1.20 | 0.00000616 | 1964 |
Missense in Polyphen | 28 | 24.483 | 1.1437 | 396 | ||
Synonymous | -0.363 | 54 | 50.7 | 1.06 | 0.00000226 | 566 |
Loss of Function |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | ||
East Asian | ||
Finnish | ||
European (Non-Finnish) | ||
Middle Eastern | ||
South Asian | ||
Other |
dbNSFP
Source:
- Function
- FUNCTION: Gustducin-coupled receptor immplicated in the perception of bitter compounds in the oral cavity and the gastrointestinal tract. Signals through PLCB2 and the calcium-regulated cation channel TRPM5. Activated by the sulfonyl amide sweeteners saccharin and acesulfame K. In airway epithelial cells, binding of bitter compounds increases the intracellular calcium ion concentration and stimulates ciliary beat frequency. May act as chemosensory receptors in airway epithelial cells to detect and eliminate potential noxious agents from the airways (By similarity). {ECO:0000250}.;
- Pathway
- Taste transduction - Homo sapiens (human);Signaling by GPCR;Signal Transduction;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding;G alpha (i) signalling events;GPCR downstream signalling
(Consensus)
Intolerance Scores
- loftool
- 0.978
- rvis_EVS
- 2.64
- rvis_percentile_EVS
- 98.81
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.415
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0674
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- detection of chemical stimulus involved in sensory perception of bitter taste;G protein-coupled receptor signaling pathway
- Cellular component
- plasma membrane;integral component of membrane;motile cilium;ciliary membrane
- Molecular function
- G protein-coupled receptor activity;taste receptor activity;bitter taste receptor activity